These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 67837)
41. A double blind comparison of guanethidine-and-adrenaline drops with 1% adrenaline alone in chronic simple glaucoma. Mills KB; Ridgway AE Br J Ophthalmol; 1978 May; 62(5):320-3. PubMed ID: 350265 [TBL] [Abstract][Full Text] [Related]
42. Effects of glaucoma medications on the cardiorespiratory and intraocular pressure status of newly diagnosed glaucoma patients. Waldock A; Snape J; Graham CM Br J Ophthalmol; 2000 Jul; 84(7):710-3. PubMed ID: 10873979 [TBL] [Abstract][Full Text] [Related]
43. [Treatment of glaucoma chronicum simplex with a combination of 0.5 percent timolol with 0.5 percent adrenaline plus 0.3 percent guanethidine]. Pfeiffer N; Grehn F Klin Monbl Augenheilkd; 1989 Mar; 194(3):161-3. PubMed ID: 2657199 [TBL] [Abstract][Full Text] [Related]
44. Additive intraocular pressure-lowering effects of the Rho kinase inhibitor ripasudil in Japanese patients with various subtypes of glaucoma. Komizo T; Ono T; Yagi A; Miyata K; Aihara M Jpn J Ophthalmol; 2019 Jan; 63(1):40-45. PubMed ID: 30368633 [TBL] [Abstract][Full Text] [Related]
45. [The effect of a mixture of aceclidine and adrenaline on intraocular pressure of patients showing open-angle glaucoma]. Collignon J; Prijot E Ophthalmologica; 1970; 161(4):394-401. PubMed ID: 5483905 [No Abstract] [Full Text] [Related]
46. [A comparison study of pulsitile ocular blood flow in normal eyes and primary open angle glaucoma]. Zhang MZ; Fu ZF; Liu XR; Zheng C Zhonghua Yan Ke Za Zhi; 2004 Apr; 40(4):250-3. PubMed ID: 15268833 [TBL] [Abstract][Full Text] [Related]
47. Timolol and epinephrine. Comparisin of efficacy and side effects. Sonntag JR; Brindley GO; Shields MB; Arafat NI; Phelps CD Arch Ophthalmol; 1979 Feb; 97(2):273-7. PubMed ID: 399179 [No Abstract] [Full Text] [Related]
48. Low centration guanethidine and adrenaline therapy of glaucoma. A preliminary report. Nagasubramanian S; Tripathi RC; Poinoosawmy D; Gloster J Trans Ophthalmol Soc U K (1962); 1976 Apr; 96(1):179-83. PubMed ID: 1070852 [No Abstract] [Full Text] [Related]
51. Ocular hypotensive efficacy of topical epinephrine in normotensive and hypertensive rabbits: continuous drug delivery vs eyedrops. Birss SA; Longwell A; Heckbert S; Keller N Ann Ophthalmol; 1978 Aug; 10(8):1045-54. PubMed ID: 29554 [TBL] [Abstract][Full Text] [Related]
52. Timolol v guanethidine-epinephrine formulations in the treatment of glaucoma. An open clinical trial. Hoyng PF; Verbey NL Arch Ophthalmol; 1984 Dec; 102(12):1788-93. PubMed ID: 6391441 [TBL] [Abstract][Full Text] [Related]
53. Systemic effects of eye drops. Davidson SI Trans Ophthalmol Soc U K (1962); 1974 Jul; 94(2):487-95. PubMed ID: 4143267 [No Abstract] [Full Text] [Related]
54. Association of open-angle glaucoma with perfusion pressure status in the Thessaloniki Eye Study. Topouzis F; Wilson MR; Harris A; Founti P; Yu F; Anastasopoulos E; Pappas T; Koskosas A; Salonikiou A; Coleman AL Am J Ophthalmol; 2013 May; 155(5):843-51. PubMed ID: 23394905 [TBL] [Abstract][Full Text] [Related]
55. Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension. Netland PA; Landry T; Sullivan EK; Andrew R; Silver L; Weiner A; Mallick S; Dickerson J; Bergamini MV; Robertson SM; Davis AA; Am J Ophthalmol; 2001 Oct; 132(4):472-84. PubMed ID: 11589866 [TBL] [Abstract][Full Text] [Related]
56. Clinical experience of glaucoma therapy with tosmilen eye drops. Geijer T; Peterson H Acta Ophthalmol (Copenh); 1966; 44(1):69-77. PubMed ID: 5952961 [No Abstract] [Full Text] [Related]
57. Timolol and epinephrine in primary open angle glaucoma. Transient additive effect. Thomas JV; Epstein DL Arch Ophthalmol; 1981 Jan; 99(1):91-5. PubMed ID: 7006581 [TBL] [Abstract][Full Text] [Related]
58. [Changes in biomechanical properties of the ocular fibrous tunic in patients with primary open-angle glaucoma in response to drug-induced stress-relief tests]. Makashova NV; Vasilyeva AE Vestn Oftalmol; 2017; 133(4):31-36. PubMed ID: 28980563 [TBL] [Abstract][Full Text] [Related]